Kawada Manabu

カワダマナブ | Kawada Manabu

Affiliation and department：
Job title： Chief Researcher
Other affiliations (1)：

Homepage URL (1)： http://www.bikaken.or.jp/

Research field (1)： Cell biology

Research keywords (2)： Anti-cancer drug , Tumor-stromal cell interactions

Research theme for competitive and other funds (14)：

2022 - 2028 先端モデル動物支援プラットフォーム
2016 - 2021 先端モデル動物支援プラットフォーム
2015 - 2018 Development and mechanism analysis of small molecules affecting tumor-stromal cell interactions
2010 - 2016 Scientific Support Programs for Cancer Research Grant-in-Aid for Scientific Research on Innovative Areas
2011 - 2013 がん微小環境を制御する低分子プローブの開発

Show all

Papers (147)：

Daisuke Tatsuda, Masahide Amemiya, Chisato Nosaka, Ryuichi Sawa, Hideyuki Muramatsu, Masayuki Igarashi, Junjiro Yoshida, Tomokazu Ohishi, Manabu Kawada. Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells. The Journal of antibiotics. 2023
Hiroyuki Suzuki, Tomokazu Ohishi, Ren Nanamiya, Manabu Kawada, Mika K Kaneko, Yukinari Kato. Defucosylated Monoclonal Antibody (H2Mab-139-mG2a-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2. Current issues in molecular biology. 2023. 45. 10. 7734-7748
Daisuke Tatsuda, Junjiro Yoshida, Tomokazu Ohishi, Manabu Kawada. Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells. Anticancer research. 2023. 43. 6. 2477-2489
Guanjie Li, Hiroyuki Suzuki, Tomokazu Ohishi, Teizo Asano, Tomohiro Tanaka, Miyuki Yanaka, Takuro Nakamura, Takeo Yoshikawa, Manabu Kawada, Mika K Kaneko, et al. Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models. International journal of molecular medicine. 2023. 51. 2
Tomokazu Ohishi, Mika K Kaneko, Yukihiro Yoshida, Atsuo Takashima, Yukinari Kato, Manabu Kawada. Current Targeted Therapy for Metastatic Colorectal Cancer. International journal of molecular sciences. 2023. 24. 2

ｍore...

MISC (71)：

大石智一, 川田学. Involvement of the fibrinolytic system regulator in the liver metastasis of colorectal cancer. 日本がん転移学会学術集会・総会プログラム抄録集. 2021. 30th
田中智大, 大石智一, 川田学, 金子美華, 加藤幸成. 抗TROP2モノクローナル抗体TrMab-6の乳がんモデルに対する抗腫瘍効果. 日本癌学会学術総会抄録集(Web). 2021. 80th
細野ヒデキ, 大石智一, 淺野禎三, 金子美華, 川田学, 加藤幸成, 加藤幸成. 新規抗EpCAM抗体(EpMab-16)の大腸がんに対する抗腫瘍活性の評価. 日本生化学会大会(Web). 2021. 94th
大石智一, 加藤幸成, 大庭俊一, 川田学. Novel anti-EGFR monoclonal antibody EMab-17 exerts anti-tumor activity for colon cancer. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2021. 25th
七宮蓮, 武井潤子, 武井潤子, 大石智一, 川田学, 原田浩之, 金子美華, 加藤幸成, 加藤幸成. 新規抗EGFRモノクローナル抗体134-mG2aの口腔扁平上皮がん移植片モデルにおける抗腫瘍効果の検討. 日本癌学会学術総会抄録集(Web). 2021. 80th

ｍore...

Professional career (1)：

Committee career (3)：

Awards (4)：

Association Membership(s) (5)：

日本がん転移学会 , 日本がん分子標的治療学会 , 日本生化学会 , 日本癌学会 , American Society for Biochemistry and Molecular Biology

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page